Rahima Benhabbour, PhD, a biomedical engineering professor at NC State University and UNC-Chapel Hill, is leading a groundbreaking effort to revolutionize women’s health. She is developing the AnelleO PRO, the first 3D-printed intravaginal ring that offers a self-administered, controlled release of progesterone to treat infertility. Unlike traditional methods that require daily injections, this ring provides a month’s worth of treatment. Benhabbour’s work focuses on creating affordable, accessible, and empowering drug delivery systems for women, especially in regions with high HIV prevalence like sub-Saharan Africa.
Her research, which has also explored treatments for HIV, chronic pain, and menopause, aims to address long-standing gaps in women’s healthcare. The AnelleO PRO, developed using continuous liquid interface production (CLIP) 3D printing, overcomes limitations of conventional drug delivery systems and is designed to be comfortable and effective for all women.
Benhabbour’s team is now working on clinical trials and FDA approval, with plans to extend the technology to other women’s health issues, such as cancer and menopausal hormone therapy. She emphasizes the need for greater collaboration across research, clinical, and policy sectors to improve women’s health and ensure innovative, personalized treatments. The project, led by a predominantly female team, highlights the importance of women in STEM, especially in advancing healthcare for women.
To read the full article on the UNC Health and UNC School of Medicine website click here.